AUTOLUS THERAPEUTICS PLC (AUTL) Stock Analyst Earnings Estimates
NASDAQ:AUTL - Nasdaq - US05280R1005 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.33M 35.47% | 6.36M 172.96% | 1.698M -73.30% | 12.913M 660.48% | 37.921M 193.67% | 128.76M 239.55% | 309.41M 140.30% | 521.7M 68.61% | 641.95M 23.05% | 699.41M 8.95% | 697.95M -0.21% | 708.77M 1.55% | |
| EBITDA YoY % growth | -155.86M 4.08% | -160.11M -2.73% | -168.963M -5.53% | -210.108M -24.35% | -201.009M 4.33% | -143.37M 28.67% | -204.315M -42.51% | -15.29M 92.52% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -164.32M 2.28% | -167.53M -1.95% | -175.528M -4.77% | -224.425M -27.86% | -230.261M -2.60% | -186.248M 19.11% | -27.505M 85.23% | 155.62M 665.78% | 323.32M 107.76% | 355.93M 10.09% | 442.19M 24.24% | 493.52M 11.61% | |
| Operating Margin | -7,052.36% | -2,634.12% | -10,337.34% | -1,737.98% | -607.21% | -144.65% | -8.89% | 29.83% | 50.37% | 50.89% | 63.36% | 69.63% | |
| EPS YoY % growth | -1.97 28.88% | -1.57 20.36% | -1.20 23.52% | -0.94 22.01% | -0.89 4.92% | -0.79 11.29% | -0.34 56.56% | 0.27 178.11% | 1.01 278.90% | 1.17 15.58% | 1.26 7.83% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 53.37% | -0.26 -8.38% | -0.27 -20.55% | -0.26 17.74% | -0.22 -5.33% | -0.24 5.88% | -0.23 11.54% | -0.23 8.00% | -0.22 -1.54% |
| Revenue Q2Q % growth | 3.039M | 1.088M -89.22% | 4.389M | 8.712M | 11.021M 262.65% | 19.754M 1,715.63% | 23.211M 428.84% | 26.174M 200.44% | 29.632M 168.87% |
| EBITDA Q2Q % growth | -67.728M -97.34% | -66.198M -79.15% | -69.768M -41.61% | -69.258M -11.68% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -69.995M -71.19% | -67.626M -74.49% | -68.961M -36.38% | -68.924M -1.88% | -66.209M 5.41% | -64.83M 4.13% | -63.092M 8.51% | -62.408M 9.45% | -60.498M 8.63% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.31 -19.23% | -0.22 | -0.09 | -41.83% |
| Q2 2024 Q2Q % growth | -0.22 15.38% | -0.20 | -0.02 | -11.01% |
| Q1 2024 Q2Q % growth | -0.24 -4.35% | -0.06 | -0.18 | -327.81% |
| Q4 2023 Q2Q % growth | -0.45 -95.65% | -0.26 | -0.19 | -74.72% |
| Q3 2023 Q2Q % growth | -0.26 44.56% | -0.26 | -0.01 | -1.96% |
| Q2 2023 Q2Q % growth | -0.26 43.48% | -0.23 | -0.03 | -13.65% |
| Q1 2023 Q2Q % growth | -0.23 43.90% | -0.27 | 0.04 | 15.31% |
| Q4 2022 Q2Q % growth | -0.23 54.90% | -0.27 | 0.04 | 16.10% |
| Q3 2022 Q2Q % growth | -0.47 0.21% | -0.47 | 0.00 | 1.00% |
| Q2 2022 Q2Q % growth | -0.46 2.13% | -0.43 | -0.03 | -7.38% |
| Q1 2022 Q2Q % growth | -0.41 21.15% | -0.49 | 0.08 | 16.45% |
| Q4 2021 Q2Q % growth | -0.51 38.55% | -0.47 | -0.04 | -8.36% |
| Q3 2021 Q2Q % growth | -0.47 34.72% | -0.52 | 0.05 | 8.86% |
| Q2 2021 Q2Q % growth | -0.47 24.19% | -0.51 | 0.04 | 7.64% |
| Q1 2021 Q2Q % growth | -0.52 13.33% | -0.62 | 0.10 | 15.67% |
| Q4 2020 Q2Q % growth | -0.83 1.19% | -0.78 | -0.05 | -6.29% |
| Q3 2020 Q2Q % growth | -0.72 -18.03% | -0.72 | 0.00 | 0.11% |
| Q2 2020 Q2Q % growth | -0.62 4.62% | -0.72 | 0.10 | 14.25% |
| Q1 2020 Q2Q % growth | -0.60 13.04% | -0.76 | 0.16 | 20.69% |
| Q4 2019 Q2Q % growth | -0.84 | -0.75 | -0.09 | -11.54% |
| Q3 2019 Q2Q % growth | -0.61 | -0.86 | 0.25 | 29.23% |
| Q2 2019 Q2Q % growth | -0.65 | -0.77 | 0.12 | 15.93% |
| Q1 2019 Q2Q % growth | -0.69 | -0.59 | -0.10 | -16.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 131.753K | -131.753K | -100.00% |
| Q2 2024 Q2Q % growth | 63.75K | -63.75K | -100.00% | |
| Q1 2024 Q2Q % growth | 10.091M 681.04% | 25.5M | -15.409M | -60.43% |
| Q4 2023 Q2Q % growth | -100.00% | 365.568K | -365.568K | -100.00% |
| Q3 2023 Q2Q % growth | 406K -82.87% | 455.216K | -49.216K | -10.81% |
| Q2 2023 Q2Q % growth | 139.23K | -139.23K | -100.00% | |
| Q1 2023 Q2Q % growth | 1.292M 660.00% | 360.193K | 931.807K | 258.70% |
| Q4 2022 Q2Q % growth | 3.83M 2,027.78% | 3.262M | 568K | 17.41% |
| Q3 2022 Q2Q % growth | 2.37M 887.50% | 137.7K | 2.232M | 1,621.13% |
| Q2 2022 Q2Q % growth | -100.00% | 245.371K | -245.371K | -100.00% |
| Q1 2022 Q2Q % growth | 170K -37.04% | 288.517K | -118.517K | -41.08% |
| Q4 2021 Q2Q % growth | 180K -55.00% | 200.94K | -20.94K | -10.42% |
| Q3 2021 Q2Q % growth | 240K -64.71% | 253.297K | -13.297K | -5.25% |
| Q2 2021 Q2Q % growth | 1.65M 468.97% | 197.992K | 1.452M | 733.37% |
| Q1 2021 Q2Q % growth | 270K -20.59% | 351.778K | -81.778K | -23.25% |
| Q4 2020 Q2Q % growth | 400K 29.03% | 346.678K | 53.322K | 15.38% |
| Q3 2020 Q2Q % growth | 680K 126.67% | 309.172K | 370.828K | 119.94% |
| Q2 2020 Q2Q % growth | 290K -14.71% | 385.121K | -95.121K | -24.70% |
| Q1 2020 Q2Q % growth | 340K -82.65% | 612K | -272K | -44.44% |
| Q4 2019 Q2Q % growth | 310K | 529.584K | -219.584K | -41.46% |
| Q3 2019 Q2Q % growth | 300K | 591.6K | -291.6K | -49.29% |
| Q2 2019 Q2Q % growth | 340K | 637.5K | -297.5K | -46.67% |
| Q1 2019 Q2Q % growth | 1.96M | 102K | 1.858M | 1,821.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 7.89% | 7.89% | -2.96% | -11.74% |
| Revenue | -15.23% | -15.23% | -20.1% | -17.04% |